Kanabo switches its emphasis towards cannabis prescribing and dispensing

UK-based medical cannabis company Kanabo will look to focus on “last mile assets” such as dispensing and prescribing as it responds to changing market conditions. That change of emphasis, announced during the company’s presentation of its 2021 year end results, is reflected in recent acquisition activity.

But the £36m purchase of Materia, a processor and distributor of medical cannabis and CBD wellness products, that had been in the works for about a year, has been scrapped in favour of a strategic partnership.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Pablo Sharrock
+34 722 642 678
Email Pablo

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ Kanabo switches its emphasis towards cannabis prescribing and dispensing ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Kanabo switches its emphasis towards cannabis prescribing and dispensing ”






      UK-based medical cannabis company Kanabo will look to focus on “last mile assets” such as dispensing and prescribing as it responds to changing market conditions. That change of emphasis, announced during the company’s presentation of its 2021 year end results, is reflected in recent acquisition activity.

      But the £36m purchase of Materia, a processor and distributor of medical cannabis and CBD wellness products, that had been in the works for about a year, has been scrapped in favour of a strategic partnership.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik

      Pablo Sharrock
      +34 722 642 678
      Email Pablo